Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients

For high-risk breast cancer patients with positive axillary lymph nodes, dose-dense every-two-week epirubicin/cyclophosphamide-paclitaxel (ddEC-P) regimen is the optimal postoperative adjuvant therapy. However, this regimen is limited by the grade 3/4 neutropenia and febrile neutropenia (FN). There...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, LingHu, RuiXia, Zhan, XingYang, Li, Ruisheng, Feng, Fan, Gao, Xudong, Zhao, Lei, Yang, Junlan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668117/
https://www.ncbi.nlm.nih.gov/pubmed/29108384
http://dx.doi.org/10.18632/oncotarget.18145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668117/
https://www.ncbi.nlm.nih.gov/pubmed/29108384
http://dx.doi.org/10.18632/oncotarget.18145

Ejemplares similares